Literature DB >> 15297654

Immunology. NK cells lose their inhibition.

Peter Parham1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15297654     DOI： 10.1126/science.1102025

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  19 in total

1.  Interaction between immunoglobulin allotypes and NK receptor genes in diabetes post-hepatitis C virus infection.

Authors:  Julio Granados-Montiel; Joaquin Zúñiga; Jose Azocar; Edmond J Feris; Daniel Terreros; Charles E Larsen; Olga P Clavijo; Alfredo Cruz-Lagunas; Derek Middleton; Chester A Alper; Janardan P Pandey; Edmond J Yunis
Journal:  Immunobiology       Date:  2010-11-05       Impact factor: 3.144

2.  HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis.

Authors:  José A Campillo; Jorge A Martínez-Escribano; Manuel Muro; Rosa Moya-Quiles; Luis A Marín; Olga Montes-Ares; Natalia Guerra; Paloma Sánchez-Pedreño; José F Frías; José A Lozano; Ana M García-Alonso; M Rocío Alvarez-López
Journal:  Immunogenetics       Date:  2005-12-20       Impact factor: 2.846

3.  Gastric cancer cells inhibit natural killer cell proliferation and induce apoptosis via prostaglandin E2.

Authors:  Tuanjie Li; Qi Zhang; Yuming Jiang; Jiang Yu; Yanfeng Hu; Tingyu Mou; Guihua Chen; Guoxin Li
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

4.  Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function.

Authors:  Sebastian Lunemann; Gloria Martrus; Angelique Hölzemer; Anais Chapel; Maja Ziegler; Christian Körner; Wilfredo Garcia Beltran; Mary Carrington; Heiner Wedemeyer; Marcus Altfeld
Journal:  J Hepatol       Date:  2016-04-04       Impact factor: 25.083

Review 5.  HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?

Authors:  Marie-Eve Blais; Tao Dong; Sarah Rowland-Jones
Journal:  Immunology       Date:  2011-03-01       Impact factor: 7.397

Review 6.  Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome.

Authors:  Viviana Romero; Jose Azocar; Joaquin Zúñiga; Olga P Clavijo; Daniel Terreros; Xiangjun Gu; Zaheed Husain; Raymond T Chung; Christopher Amos; Edmond J Yunis
Journal:  Mol Immunol       Date:  2008-03-04       Impact factor: 4.407

Review 7.  Beyond chemotherapy and targeted therapy: adoptive cellular therapy in non-small cell lung cancer.

Authors:  Junying Wang; Xueju Wang
Journal:  Mol Biol Rep       Date:  2014-06-27       Impact factor: 2.316

8.  Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance.

Authors:  Ping An; Chloe L Thio; Gregory D Kirk; Sharyne Donfield; James J Goedert; Cheryl A Winkler
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

9.  KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis.

Authors:  José A Campillo; Isabel Legaz; M Rocío López-Álvarez; José Miguel Bolarín; Beatriz Las Heras; Manuel Muro; Alfredo Minguela; María R Moya-Quiles; Rosa Blanco-García; Helios Martínez-Banaclocha; Ana M García-Alonso; M Rocío Alvarez-López; Jorge A Martínez-Escribano
Journal:  Immunogenetics       Date:  2013-01-31       Impact factor: 2.846

Review 10.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.